Global Orally Disintegrating Tablet Excipient Market Insights and Forecast to 2027

Report ID: 856885 | Published Date: Jan 2025 | No. of Page: 150 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Orally Disintegrating Tablet Excipient Product Introduction
    1.2 Market by Type
        1.2.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type
        1.4.2 Binders
        1.4.3 Glidents
        1.2.4 Diluents
        1.2.5 Disintegrants
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application
        1.3.2 Anti-Psychotics Drug
        1.3.3 Anti-Epileptics Drug
        1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts 2016-2027
    2.2 Global Orally Disintegrating Tablet Excipient Revenue Estimates and Forecasts 2016-2027
    2.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Orally Disintegrating Tablet Excipient Regions by Sales
        2.4.1 Global Top Orally Disintegrating Tablet Excipient Regions by Sales (2016-2021)
        2.4.2 Global Top Orally Disintegrating Tablet Excipient Regions by Sales (2022-2027)
    2.5 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue
        2.5.1 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue (2016-2021)
        2.5.2 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Orally Disintegrating Tablet Excipient Sales by Manufacturers
        3.1.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Excipient Sales in 2020
    3.2 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers
        3.2.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Excipient Revenue in 2020
    3.3 Global Orally Disintegrating Tablet Excipient Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Orally Disintegrating Tablet Excipient Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Orally Disintegrating Tablet Excipient Sales by Type
        4.1.1 Global Orally Disintegrating Tablet Excipient Historical Sales by Type (2016-2021)
        4.1.2 Global Orally Disintegrating Tablet Excipient Forecasted Sales by Type (2022-2027)
        4.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type
        4.2.1 Global Orally Disintegrating Tablet Excipient Historical Revenue by Type (2016-2021)
        4.2.2 Global Orally Disintegrating Tablet Excipient Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    4.3 Global Orally Disintegrating Tablet Excipient Price by Type
        4.3.1 Global Orally Disintegrating Tablet Excipient Price by Type (2016-2021)
        4.3.2 Global Orally Disintegrating Tablet Excipient Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Orally Disintegrating Tablet Excipient Sales by Application
        5.1.1 Global Orally Disintegrating Tablet Excipient Historical Sales by Application (2016-2021)
        5.1.2 Global Orally Disintegrating Tablet Excipient Forecasted Sales by Application (2022-2027)
        5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    5.2 Global Orally Disintegrating Tablet Excipient Revenue by Application
        5.2.1 Global Orally Disintegrating Tablet Excipient Historical Revenue by Application (2016-2021)
        5.2.2 Global Orally Disintegrating Tablet Excipient Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    5.3 Global Orally Disintegrating Tablet Excipient Price by Application
        5.3.1 Global Orally Disintegrating Tablet Excipient Price by Application (2016-2021)
        5.3.2 Global Orally Disintegrating Tablet Excipient Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Orally Disintegrating Tablet Excipient Market Size by Type
        6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Type (2016-2027)
        6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Type (2016-2027)
    6.2 North America Orally Disintegrating Tablet Excipient Market Size by Application
        6.2.1 North America Orally Disintegrating Tablet Excipient Sales by Application (2016-2027)
        6.2.2 North America Orally Disintegrating Tablet Excipient Revenue by Application (2016-2027)
    6.3 North America Orally Disintegrating Tablet Excipient Market Size by Country
        6.3.1 North America Orally Disintegrating Tablet Excipient Sales by Country (2016-2027)
        6.3.2 North America Orally Disintegrating Tablet Excipient Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Orally Disintegrating Tablet Excipient Market Size by Type
        7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Type (2017-2027)
        7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Type (2017-2027)
    7.2 Europe Orally Disintegrating Tablet Excipient Market Size by Application
        7.2.1 Europe Orally Disintegrating Tablet Excipient Sales by Application (2017-2027)
        7.2.2 Europe Orally Disintegrating Tablet Excipient Revenue by Application (2017-2027)
    7.3 Europe Orally Disintegrating Tablet Excipient Market Size by Country
        7.3.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2017-2027)
        7.3.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Type
        8.1.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Type (2018-2027)
        8.1.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Type (2018-2027)
    8.2 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Application
        8.2.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Application (2018-2027)
        8.2.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Application (2018-2027)
    8.3 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Region
        8.3.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2018-2027)
        8.3.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Type
        9.1.1 Latin America Orally Disintegrating Tablet Excipient Sales by Type (2019-2027)
        9.1.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Type (2019-2027)
    9.2 Latin America Orally Disintegrating Tablet Excipient Market Size by Application
        9.2.1 Latin America Orally Disintegrating Tablet Excipient Sales by Application (2019-2027)
        9.2.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Application (2019-2027)
    9.3 Latin America Orally Disintegrating Tablet Excipient Market Size by Country
        9.3.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2019-2027)
        9.3.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Type
        6.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Type (2016-2027)
    6.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Application
        6.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Application (2016-2027)
    6.3 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country
        6.3.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 BASF
        11.1.1 BASF Corporation Information
        11.1.2 BASF Overview
        11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 BASF Orally Disintegrating Tablet Excipient Product Description
        11.1.5 BASF Related Developments
    11.2 JRS Pharma
        11.2.1 JRS Pharma Corporation Information
        11.2.2 JRS Pharma Overview
        11.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Description
        11.2.5 JRS Pharma Related Developments
    11.3 Roquette
        11.3.1 Roquette Corporation Information
        11.3.2 Roquette Overview
        11.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Roquette Orally Disintegrating Tablet Excipient Product Description
        11.3.5 Roquette Related Developments
    11.4 ABF Ingredients
        11.4.1 ABF Ingredients Corporation Information
        11.4.2 ABF Ingredients Overview
        11.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Description
        11.4.5 ABF Ingredients Related Developments
    11.5 DFE Pharma
        11.5.1 DFE Pharma Corporation Information
        11.5.2 DFE Pharma Overview
        11.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Description
        11.5.5 DFE Pharma Related Developments
    11.6 Evonik
        11.6.1 Evonik Corporation Information
        11.6.2 Evonik Overview
        11.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Evonik Orally Disintegrating Tablet Excipient Product Description
        11.6.5 Evonik Related Developments
    11.7 Merck KGaA
        11.7.1 Merck KGaA Corporation Information
        11.7.2 Merck KGaA Overview
        11.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Description
        11.7.5 Merck KGaA Related Developments
    11.8 Ashland
        11.8.1 Ashland Corporation Information
        11.8.2 Ashland Overview
        11.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Ashland Orally Disintegrating Tablet Excipient Product Description
        11.8.5 Ashland Related Developments
    11.9 Meggle Pharma
        11.9.1 Meggle Pharma Corporation Information
        11.9.2 Meggle Pharma Overview
        11.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Description
        11.9.5 Meggle Pharma Related Developments
    11.10 Shin-Etsu
        11.10.1 Shin-Etsu Corporation Information
        11.10.2 Shin-Etsu Overview
        11.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Description
        11.10.5 Shin-Etsu Related Developments
    11.1 BASF
        11.1.1 BASF Corporation Information
        11.1.2 BASF Overview
        11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 BASF Orally Disintegrating Tablet Excipient Product Description
        11.1.5 BASF Related Developments
    11.12 McePharma (Vivesa holding)
        11.12.1 McePharma (Vivesa holding) Corporation Information
        11.12.2 McePharma (Vivesa holding) Overview
        11.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.12.4 McePharma (Vivesa holding) Product Description
        11.12.5 McePharma (Vivesa holding) Related Developments
    11.13 Cargill Incorporated
        11.13.1 Cargill Incorporated Corporation Information
        11.13.2 Cargill Incorporated Overview
        11.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.13.4 Cargill Incorporated Product Description
        11.13.5 Cargill Incorporated Related Developments
    11.14 Daicel Corporation
        11.14.1 Daicel Corporation Corporation Information
        11.14.2 Daicel Corporation Overview
        11.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.14.4 Daicel Corporation Product Description
        11.14.5 Daicel Corporation Related Developments
    11.15 Anhui Sunhere Pharmaceutical
        11.15.1 Anhui Sunhere Pharmaceutical Corporation Information
        11.15.2 Anhui Sunhere Pharmaceutical Overview
        11.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
        11.15.4 Anhui Sunhere Pharmaceutical Product Description
        11.15.5 Anhui Sunhere Pharmaceutical Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
    12.2 Orally Disintegrating Tablet Excipient Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Orally Disintegrating Tablet Excipient Production Mode & Process
    12.4 Orally Disintegrating Tablet Excipient Sales and Marketing
        12.4.1 Orally Disintegrating Tablet Excipient Sales Channels
        12.4.2 Orally Disintegrating Tablet Excipient Distributors
    12.5 Orally Disintegrating Tablet Excipient Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Orally Disintegrating Tablet Excipient Industry Trends
    13.2 Orally Disintegrating Tablet Excipient Market Drivers
    13.3 Orally Disintegrating Tablet Excipient Market Challenges
    13.4 Orally Disintegrating Tablet Excipient Market Restraints

14 Key Findings in The Global Orally Disintegrating Tablet Excipient Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Binders
    Table 3. Major Manufacturers of Glidents
    Table 4. Major Manufacturers of Diluents
    Table 5. Major Manufacturers of Disintegrants
    Table 6. Major Manufacturers of Others
    Table 7. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Orally Disintegrating Tablet Excipient Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 9. Global Orally Disintegrating Tablet Excipient Sales by Region (2016-2021) & (K MT)
    Table 10. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
    Table 11. Global Orally Disintegrating Tablet Excipient Sales by Region (2016-2021) & (K MT)
    Table 12. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2022-2027)
    Table 13. Global Orally Disintegrating Tablet Excipient Revenue by Region (2016-2021) & (US$ Million)
    Table 14. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2016-2021)
    Table 15. Global Orally Disintegrating Tablet Excipient Revenue by Region (2022-2027) & (US$ Million)
    Table 16. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2022-2027)
    Table 17. Global Orally Disintegrating Tablet Excipient Sales by Manufacturers (2016-2021) & (K MT)
    Table 18. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturers (2016-2021)
    Table 19. Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 20. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2016-2021)
    Table 21. Orally Disintegrating Tablet Excipient Price by Manufacturers 2016-2021 (USD/MT)
    Table 22. Global Orally Disintegrating Tablet Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2020)
    Table 24. Orally Disintegrating Tablet Excipient Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Orally Disintegrating Tablet Excipient Product Offered
    Table 26. Date of Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 29. Global Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 30. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2016-2021)
    Table 31. Global Orally Disintegrating Tablet Excipient Sales Share by Type (2022-2027)
    Table 32. Global Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 33. Global Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 34. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2016-2021)
    Table 35. Global Orally Disintegrating Tablet Excipient Revenue Share by Type (2022-2027)
    Table 36. Orally Disintegrating Tablet Excipient Price by Type (2016-2021) & (USD/MT)
    Table 37. Global Orally Disintegrating Tablet Excipient Price Forecast by Type (2022-2027) & (USD/MT)
    Table 38. Global Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 39. Global Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 40. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2016-2021)
    Table 41. Global Orally Disintegrating Tablet Excipient Sales Share by Application (2022-2027)
    Table 42. Global Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 43. Global Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 44. Global Orally Disintegrating Tablet Excipient Revenue Share by Application (2016-2021)
    Table 45. Global Orally Disintegrating Tablet Excipient Revenue Share by Application (2022-2027)
    Table 46. Orally Disintegrating Tablet Excipient Price by Application (2016-2021) & (USD/MT)
    Table 47. Global Orally Disintegrating Tablet Excipient Price Forecast by Application (2022-2027) & (USD/MT)
    Table 48. North America Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 49. North America Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 50. North America Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 51. North America Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 52. North America Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 53. North America Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 54. North America Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 55. North America Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 56. North America Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
    Table 57. North America Orally Disintegrating Tablet Excipient Sales by Country (2022-2027) & (K MT)
    Table 58. North America Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & (US$ Million)
    Table 59. North America Orally Disintegrating Tablet Excipient Revenue by Country (2022-2027) & (US$ Million)
    Table 60. Europe Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 61. Europe Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 62. Europe Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 63. Europe Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 64. Europe Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 65. Europe Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 66. Europe Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 67. Europe Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 68. Europe Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
    Table 69. Europe Orally Disintegrating Tablet Excipient Sales by Country (2022-2027) & (K MT)
    Table 70. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & (US$ Million)
    Table 71. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2022-2027) & (US$ Million)
    Table 72. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 73. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 74. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 76. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 77. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 78. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 79. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 80. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2016-2021) & (K MT)
    Table 81. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2022-2027) & (K MT)
    Table 82. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2016-2021) & (US$ Million)
    Table 83. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2022-2027) & (US$ Million)
    Table 84. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 85. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 86. Latin America Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 87. Latin America Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 88. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 89. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 90. Latin America Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 91. Latin America Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 92. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
    Table 93. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2022-2027) & (K MT)
    Table 94. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & (US$ Million)
    Table 95. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2022-2027) & (US$ Million)
    Table 96. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2016-2021) & (K MT)
    Table 97. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2022-2027) & (K MT)
    Table 98. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Type (2016-2021) & (US$ Million)
    Table 99. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Type (2022-2027) & (US$ Million)
    Table 100. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2016-2021) & (K MT)
    Table 101. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2022-2027) & (K MT)
    Table 102. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Application (2016-2021) & (US$ Million)
    Table 103. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Application (2022-2027) & (US$ Million)
    Table 104. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2016-2021) & (K MT)
    Table 105. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2022-2027) & (K MT)
    Table 106. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2016-2021) & (US$ Million)
    Table 107. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2022-2027) & (US$ Million)
    Table 108. BASF Corporation Information
    Table 109. BASF Description and Major Businesses
    Table 110. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 111. BASF Orally Disintegrating Tablet Excipient Product
    Table 112. BASF Recent Developments
    Table 113. JRS Pharma Corporation Information
    Table 114. JRS Pharma Description and Major Businesses
    Table 115. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 116. JRS Pharma Orally Disintegrating Tablet Excipient Product
    Table 117. JRS Pharma Recent Developments
    Table 118. Roquette Corporation Information
    Table 119. Roquette Description and Major Businesses
    Table 120. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 121. Roquette Orally Disintegrating Tablet Excipient Product
    Table 122. Roquette Recent Developments
    Table 123. ABF Ingredients Corporation Information
    Table 124. ABF Ingredients Description and Major Businesses
    Table 125. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 126. ABF Ingredients Orally Disintegrating Tablet Excipient Product
    Table 127. ABF Ingredients Recent Developments
    Table 128. DFE Pharma Corporation Information
    Table 129. DFE Pharma Description and Major Businesses
    Table 130. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 131. DFE Pharma Orally Disintegrating Tablet Excipient Product
    Table 132. DFE Pharma Recent Developments
    Table 133. Evonik Corporation Information
    Table 134. Evonik Description and Major Businesses
    Table 135. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 136. Evonik Orally Disintegrating Tablet Excipient Product
    Table 137. Evonik Recent Developments
    Table 138. Merck KGaA Corporation Information
    Table 139. Merck KGaA Description and Major Businesses
    Table 140. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 141. Merck KGaA Orally Disintegrating Tablet Excipient Product
    Table 142. Merck KGaA Recent Developments
    Table 143. Ashland Corporation Information
    Table 144. Ashland Description and Major Businesses
    Table 145. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 146. Ashland Orally Disintegrating Tablet Excipient Product
    Table 147. Ashland Recent Developments
    Table 148. Meggle Pharma Corporation Information
    Table 149. Meggle Pharma Description and Major Businesses
    Table 150. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 151. Meggle Pharma Orally Disintegrating Tablet Excipient Product
    Table 152. Meggle Pharma Recent Developments
    Table 153. Shin-Etsu Corporation Information
    Table 154. Shin-Etsu Description and Major Businesses
    Table 155. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 156. Shin-Etsu Orally Disintegrating Tablet Excipient Product
    Table 157. Shin-Etsu Recent Developments
    Table 158. Fuji Chemical Industries Corporation Information
    Table 159. Fuji Chemical Industries Description and Major Businesses
    Table 160. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 161. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
    Table 162. Fuji Chemical Industries Recent Developments
    Table 163. McePharma (Vivesa holding) Corporation Information
    Table 164. McePharma (Vivesa holding) Description and Major Businesses
    Table 165. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 166. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
    Table 167. McePharma (Vivesa holding) Recent Developments
    Table 168. Cargill Incorporated Corporation Information
    Table 169. Cargill Incorporated Description and Major Businesses
    Table 170. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 171. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
    Table 172. Cargill Incorporated Recent Developments
    Table 173. Daicel Corporation Corporation Information
    Table 174. Daicel Corporation Description and Major Businesses
    Table 175. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 176. Daicel Corporation Orally Disintegrating Tablet Excipient Product
    Table 177. Daicel Corporation Recent Developments
    Table 178. Anhui Sunhere Pharmaceutical Corporation Information
    Table 179. Anhui Sunhere Pharmaceutical Description and Major Businesses
    Table 180. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 181. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
    Table 182. Anhui Sunhere Pharmaceutical Recent Developments
    Table 183. Key Raw Materials Lists
    Table 184. Raw Materials Key Suppliers Lists
    Table 185. Orally Disintegrating Tablet Excipient Distributors List
    Table 186. Orally Disintegrating Tablet Excipient Customers List
    Table 187. Orally Disintegrating Tablet Excipient Market Trends
    Table 188. Orally Disintegrating Tablet Excipient Market Drivers
    Table 189. Orally Disintegrating Tablet Excipient Market Challenges
    Table 190. Orally Disintegrating Tablet Excipient Market Restraints
    Table 191. Research Programs/Design for This Report
    Table 192. Key Data Information from Secondary Sources
    Table 193. Key Data Information from Primary Sources
List of Figures
    Figure 1. Orally Disintegrating Tablet Excipient Product Picture
    Figure 2. Global Orally Disintegrating Tablet Excipient Market Share by Type in 2020 & 2027
    Figure 3. Binders Product Picture
    Figure 4. Glidents Product Picture
    Figure 5. Diluents Product Picture
    Figure 6. Disintegrants Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2020 & 2027
    Figure 9. Anti-Psychotics Drug
    Figure 10. Anti-Epileptics Drug
    Figure 11. Others
    Figure 12. Orally Disintegrating Tablet Excipient Report Years Considered
    Figure 13. Global Orally Disintegrating Tablet Excipient Sales 2016-2027 (K MT)
    Figure 14. Global Orally Disintegrating Tablet Excipient Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Orally Disintegrating Tablet Excipient Revenue 2016-2027 (US$ Million)
    Figure 16. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 17. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2016-2021)
    Figure 18. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2022-2027)
    Figure 19. North America Orally Disintegrating Tablet Excipient Sales YoY (2016-2027) & (K MT)
    Figure 20. North America Orally Disintegrating Tablet Excipient Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Europe Orally Disintegrating Tablet Excipient Sales YoY (2016-2027) & (K MT)
    Figure 22. Europe Orally Disintegrating Tablet Excipient Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Asia-Pacific Orally Disintegrating Tablet Excipient Sales YoY (2016-2027) & (K MT)
    Figure 24. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Latin America Orally Disintegrating Tablet Excipient Sales YoY (2016-2027) & (K MT)
    Figure 26. Latin America Orally Disintegrating Tablet Excipient Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. Middle East & Africa Orally Disintegrating Tablet Excipient Sales YoY (2016-2027) & (K MT)
    Figure 28. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue YoY (2016-2027) & (US$ Million)
    Figure 29. The Top 10 and Top 5 Players Market Share by Orally Disintegrating Tablet Excipient Sales in 2020
    Figure 30. The Top 10 and Top 5 Players Market Share by Orally Disintegrating Tablet Excipient Revenue in 2020
    Figure 31. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 32. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 33. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 34. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 35. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 36. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 37. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 38. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 39. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 40. North America Orally Disintegrating Tablet Excipient Sales Share by Country (2016-2027)
    Figure 41. North America Orally Disintegrating Tablet Excipient Revenue Share by Country (2016-2027)
    Figure 42. U.S. Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 43. Canada Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 44. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 45. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 46. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 47. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 48. Europe Orally Disintegrating Tablet Excipient Sales Share by Country (2016-2027)
    Figure 49. Europe Orally Disintegrating Tablet Excipient Revenue Share by Country (2016-2027)
    Figure 50. Germany Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 51. France Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 52. U.K. Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 53. Italy Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 54. Russia Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 55. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 57. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 59. Asia Pacific Orally Disintegrating Tablet Excipient Sales Share by Region (2016-2027)
    Figure 60. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Share by Region (2016-2027)
    Figure 61. China Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 62. Japan Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 63. South Korea Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 64. India Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 65. Australia Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 66. Taiwan Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 67. Indonesia Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 68. Thailand Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 69. Malaysia Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 70. Philippines Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 71. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 72. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 73. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 74. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 75. Latin America Orally Disintegrating Tablet Excipient Sales Share by Country (2016-2027)
    Figure 76. Latin America Orally Disintegrating Tablet Excipient Revenue Share by Country (2016-2027)
    Figure 77. Mexico Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 78. Brazil Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 79. Argentina Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 80. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
    Figure 82. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
    Figure 84. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Share by Country (2016-2027)
    Figure 85. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Share by Country (2016-2027)
    Figure 86. Turkey Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 87. Saudi Arabia Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 88. U.A.E Orally Disintegrating Tablet Excipient Revenue (2016-2027) & (US$ Million)
    Figure 89. Orally Disintegrating Tablet Excipient Value Chain
    Figure 90. Orally Disintegrating Tablet Excipient Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Frequently Asked Questions
Orally Disintegrating Tablet Excipient report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Orally Disintegrating Tablet Excipient report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Orally Disintegrating Tablet Excipient report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Digoxin

Digoxin market is segmented by Type, and by Application. Players, stakeholders, and other partici ... Read More

Levothyroxine Sodium

Levothyroxine Sodium market is segmented by Type, and by Application. Players, stakeholders, and  ... Read More

Diamantane

Diamantane market is segmented by Type, and by Application. Players, stakeholders, and other part ... Read More